MARLBOROUGH, Mass., Feb. 13, 2020 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced the closing of its previously announced underwritten public offering of 993,633 units a

RICHFIELD, Minn., Feb. 13, 2020 /PRNewswire/ -- The 2020 Fraser Walk for Autism, presented by Central Roofing Company, will be held Saturday, April 18, on the first floor of Mall of America from 7-9 a.m. The sensory-friendly, family event features therapy animals, activities, games, performances, mascots, prizes

DECATUR, Texas, Feb. 13, 2020 /PRNewswire/ -- Wise Health System in Decatur, TX, has started sending notifications to patients to inform them that some of their protected health information (PHI) has been exposed as a result of a phishing attack. 66,934 patients have potentially been affected.The attack occurred on

NEWPORT BEACH, Calif., Feb. 13, 2020 /PRNewswire/ -- Todd De Voe, MPA, has been approved by the Certification Commission to receive the Certified Emergency Manager (CEM®) credential. The CEM® designation is the highest honor of professional achievement available from the International Association of Emergency Managers (IAEM).

WASHINGTON, Feb. 13, 2020 /PRNewswire/ -- Tarik F. Haydar, Ph.D., an award-winning neurobiologist whose research teases out how brain development differs in people with typical cognitive function compared with people with developmental disabilities, like

Focuses business on accelerated, near-term revenue growth with enhanced, coast-to-coast sales partnership with humble+fume Enhanced cost structure and near-term revenue generating opportunities expected to drive profitable growth Reports 17% year-over-year net revenue growth and maintains a strong liquidity position with total cash and restricted cash balance of $55 million

SOUTH SAN FRANCISCO, Calif., Feb. 13, 2020 /PRNewswire/ -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central n

LA JOLLA, Calif., Feb. 13, 2020 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative m

GARDNER, Mass., Feb. 13, 2020 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its second quarter fiscal year ended December 31, 2019.Second quarter

SCOTTSDALE, Ariz., Feb. 13, 2020 /PRNewswire/ -- Healthcare Trust of America, Inc. (NYSE: HTA) ("HTA") announced results for the quarter and year ended December 31, 2019.